- •Compared with UH, LMWH was associated with lower odds of VTE and death.
- •DOACs were associated with lower risk of DVT compared with LMWH.
- •Early VTE chemoprophylaxis was better than late administration in terms of VTE and death.
- •Many patients with acetabular fractures are underdosed with LMWH, with inadequate aFXa levels.
Level of Evidence
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Risk factors for venous thromboembolism.Circulation. 2003; 107 (I9–16, doi:10.1161/01.CIR.0000078469.07362.E6)
- Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank.Ann Surg. 2004; 240 (discussion 496-498): 490-496https://doi.org/10.1097/01.sla.0000137138.40116.6c
- Venous thromboembolism after severe trauma: incidence, risk factors and outcome.Injury. 2010; 41: 97-101https://doi.org/10.1016/j.injury.2009.06.010
- Risk factors for venous thromboembolism after acute trauma: a population-based case-cohort study.Thromb Res. 2016; 144: 40-45https://doi.org/10.1016/j.thromres.2016.03.026
- Venous thromboembolism in major trauma patients: a single-center retrospective cohort study of the epidemiology and utility of D-dimer for screening.Acute Med Surg. 2017; 4: 394-400https://doi.org/10.1002/ams2.290
- A cohort study on the incidence and outcome of pulmonary embolism in trauma and orthopedic patients.BMC Med. 2014; 12: 39https://doi.org/10.1186/1741-7015-12-39
- The incidence of venous thromboembolism following pelvic and lower extremity trauma despite adherence to modern prophylactic protocols.J Orthop Trauma. 2020; 34: 418-421https://doi.org/10.1097/BOT.0000000000001790
- Evaluation of venous thromboembolic complications in patients operated on for pelvic fracture.Orthop Traumatol Surg Res. 2018; 104: 917-921https://doi.org/10.1016/j.otsr.2018.04.017
- Incidence and risk factors of deep vein thrombosis in patients with pelvic and acetabular fractures.Clin Appl Thromb Hemost. 2019; 251076029619845066https://doi.org/10.1177/1076029619845066
- Institutional practice guidelines on management of pelvic fracture-related hemodynamic instability: do they make a difference?.J Trauma. 2005; 58: 778-782https://doi.org/10.1097/01.ta.0000158251.40760.b2
- Pelvic fractures and mortality.Iowa Orthop J. 1997; 17: 110-114
- Time to definitive fixation of pelvic and acetabular fractures.J Trauma Acute Care Surg. 2020; 89: 730-735https://doi.org/10.1097/TA.0000000000002860
- Acute definitive internal fixation of pelvic ring fractures in polytrauma patients: a feasible option.J Trauma. 2010; 68: 935-941https://doi.org/10.1097/TA.0b013e3181d27b48
- Fractures of acetabulum and pelvic ring–epidemiology and clinical outcome.Swiss Surg. 1999; 5: 47-54https://doi.org/10.1024/1023-93220.127.116.11
- Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group.J Trauma. 2002; 53: 142-164https://doi.org/10.1097/00005373-200207000-00032
- Venous Thromboembolism prophylaxis in orthopaedic trauma patients: a survey of OTA member practice patterns and OTA expert panel recommendations.J Orthop Trauma. 2015; 29: e355-e362https://doi.org/10.1097/BOT.0000000000000387
- Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest physicians evidence-based clinical practice guidelines.Chest. 2012; 141 (e278S–e325S, doi:10.1378/chest.11-2404)
- Updated guidelines to reduce venous thromboembolism in trauma patients: a western trauma association critical decisions algorithm.J Trauma Acute Care Surg. 2020; 89: 971-981https://doi.org/10.1097/TA.0000000000002830
- Venous thromboembolism prophylaxis after pelvic and acetabular fractures: a survey of orthopaedic surgeons’ current practices.J Am Acad Orthop Surg. 2020; 28: 750-755https://doi.org/10.5435/JAAOS-D-19-00409
- Anticoagulation drug therapy: a review.West J Emerg Med. 2015; 16: 11-17https://doi.org/10.5811/westjem.2014.12.22933
- Thrombo-prophylaxis in pelvic and acetabular trauma patients: a UK consensus?.Int Orthop. 2012; 36: 165-169https://doi.org/10.1007/s00264-011-1276-9
- Methods and guidelines for venous thromboembolism prevention in polytrauma patients with pelvic and acetabular fractures.Open Orthop J. 2015; 9: 313-320https://doi.org/10.2174/1874325001509010313
- Thromboprophylaxis in patients with pelvic and acetabular fractures: a short review and recommendations.Injury. 2013; 44: 1710-1720https://doi.org/10.1016/j.injury.2013.04.030
- Thromboembolism prophylaxis in orthopaedics: an update.EFORT Open Rev. 2018; 3: 136-148https://doi.org/10.1302/2058-5241.3.170018
- A systematic review of thromboprophylaxis for pelvic and acetabular fractures.J Orthop Trauma. 2009; 23: 379-384https://doi.org/10.1097/BOT.0b013e3181a5369c
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.BMJ. 2009; 339: b2535https://doi.org/10.1136/bmj.b2535
- Direct oral anticoagulants vs low-molecular-weight heparin for thromboprophylaxis in nonoperative pelvic fractures.J Am Coll Surg. 2019; 228: 89-97https://doi.org/10.1016/j.jamcollsurg.2018.09.023
- Timing of venous thromboprophylaxis in isolated severe pelvic fracture: effect on mortality and outcomes.Injury. 2019; 50: 697-702https://doi.org/10.1016/j.injury.2019.02.009
- The American college of surgeons trauma quality improvement program.Surg Clin N Am. 2012; 92 (x–xi): 441-454https://doi.org/10.1016/j.suc.2012.01.003
- Thromboprophylaxis in pelvic and acetabular trauma surgery. The role of early treatment with low-molecular-weight heparin.J Bone Jt Surg Br. 2005; 87: 209-212https://doi.org/10.1302/0301-620x.87b2.14447
- Early thromboprophylaxis with low-molecular-weight heparin is safe in patients with pelvic fracture managed nonoperatively.J Surg Res. 2017; 219: 360-365https://doi.org/10.1016/j.jss.2017.06.049
- Underdosing of prophylactic enoxaparin is common in orthopaedic trauma and predicts 90-day venous thromboembolism.J Orthop Trauma. 2019; 33: 570-576https://doi.org/10.1097/BOT.0000000000001563
- Patient preferences for venous thromboembolism prophylaxis after injury: a discrete choice experiment.BMJ Open. 2017; 7e016676https://doi.org/10.1136/bmjopen-2017-016676
- Operative spinal trauma: thromboprophylaxis with low molecular weight heparin or a direct oral anticoagulant.J Thromb Haemost. 2019; 17: 925-933https://doi.org/10.1111/jth.14439
- Lower mortality and morbidity with low-molecular-weight heparin for venous thromboembolism prophylaxis in spine trauma.Spine (Phila Pa 1976). 2020; 45: 1613-1618https://doi.org/10.1097/BRS.0000000000003664
- Direct oral anticoagulants are a potential alternative to low-molecular-weight heparin for thromboprophylaxis in trauma patients sustaining lower extremity fractures.J Surg Res. 2021; 258: 324-331https://doi.org/10.1016/j.jss.2020.10.009
- Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.J Trauma Acute Care Surg. 2017; 83: 151-158https://doi.org/10.1097/TA.0000000000001494
- Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: a patient-centered randomized controlled trial.PLoS One. 2020; 15e0235628https://doi.org/10.1371/journal.pone.0235628
- Post-discharge adherence with venous thromboembolism prophylaxis after orthopedic trauma: results from a randomized controlled trial of aspirin versus low molecular weight heparin.J Trauma Acute Care Surg. 2018; 84: 564-574https://doi.org/10.1097/TA.0000000000001771
- Early pharmacological venous thromboembolism prophylaxis is safe after operative fixation of traumatic spine fractures.Spine (Phila Pa 1976). 2015; 40: 299-304https://doi.org/10.1097/BRS.0000000000000754
- Trauma patients with lower extremity and pelvic fractures: should anti-factor Xa trough level guide prophylactic enoxaparin dose?.Int J Surg. 2018; 51: 128-132https://doi.org/10.1016/j.ijsu.2018.01.023
- The anti-factor Xa range for low molecular weight heparin thromboprophylaxis.Hematol Rep. 2015; 7: 5844https://doi.org/10.4081/hr.2015.5844
This study was exempt from institutional review board approval.